🇦🇺 Australia Country × Condition
breast cancer Clinical Trials in Australia
Active clinical trials for breast cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇦🇺 Australia
Active Trials in Australia (5)
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Enrollment
110 pts
Country
🇦🇺 Australia
Alterome Therapeutics, Inc.
View Trial → NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Enrollment
66 pts
Country
🇦🇺 Australia
BicycleTx Limited
View Trial → NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Country
🇦🇺 Australia
PMV Pharmaceuticals, Inc
View Trial → NCT05184582
Recruiting
Physical Exercise During Preoperative Chemotherapy for Breast Cancer
Enrollment
712 pts
Country
🇦🇺 Australia
Karolinska Institutet
View Trial → NCT05592938
Recruiting
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Enrollment
171 pts
Country
🇦🇺 Australia
University Health Network, Toronto
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in Australia?
There are currently 5 active clinical trials for breast cancer with sites in Australia, of which 5 are actively recruiting patients.
How can I join a breast cancer clinical trial in Australia?
To join a breast cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Australia?
Active breast cancer trials in Australia span Phase 1, Phase 2, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.